Abstract
In their Policy Forum “Genomics, Biobanks, and the trade-secret model” (15 April, p. [309][1]), R. Mitchell et al. submit that donating genetic samples for medical research is like selling a confidential commodity of potentially lucrative value, warranting individual licensing arrangements to

This publication has 4 references indexed in Scilit: